These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 36654819)
1. Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences. Barreca M; Lang N; Tarantelli C; Spriano F; Barraja P; Bertoni F Explor Target Antitumor Ther; 2022; 3(6):763-794. PubMed ID: 36654819 [TBL] [Abstract][Full Text] [Related]
2. A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy. Riccardi F; Dal Bo M; Macor P; Toffoli G Front Pharmacol; 2023; 14():1274088. PubMed ID: 37790810 [TBL] [Abstract][Full Text] [Related]
3. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)]. Tsuchikama K Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230 [TBL] [Abstract][Full Text] [Related]
4. Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. Sganga S; Riondino S; Iannantuono GM; Rosenfeld R; Roselli M; Torino F J Pers Med; 2023 Aug; 13(9):. PubMed ID: 37763107 [TBL] [Abstract][Full Text] [Related]
5. Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence. Gogia P; Ashraf H; Bhasin S; Xu Y Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568702 [TBL] [Abstract][Full Text] [Related]
6. Antibody-Drug Conjugates: The New Frontier of Chemotherapy. Ponziani S; Di Vittorio G; Pitari G; Cimini AM; Ardini M; Gentile R; Iacobelli S; Sala G; Capone E; Flavell DJ; Ippoliti R; Giansanti F Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752132 [TBL] [Abstract][Full Text] [Related]
7. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry. Hong Y; Nam SM; Moon A Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356 [TBL] [Abstract][Full Text] [Related]
8. Antibody-drug conjugates: recent advances in conjugation and linker chemistries. Tsuchikama K; An Z Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348 [TBL] [Abstract][Full Text] [Related]
9. Antibody-Drug Conjugates for Cancer Therapy. Hafeez U; Parakh S; Gan HK; Scott AM Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383 [TBL] [Abstract][Full Text] [Related]
10. Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review). Sun T; Niu X; He Q; Liu M; Qiao S; Qi RQ Mol Clin Oncol; 2023 Jun; 18(6):47. PubMed ID: 37206431 [TBL] [Abstract][Full Text] [Related]
11. Perspectives on the development of antibody-drug conjugates targeting ROR1 for hematological and solid cancers. Peng H Antib Ther; 2021 Oct; 4(4):222-227. PubMed ID: 34805745 [TBL] [Abstract][Full Text] [Related]
12. Novel development strategies and challenges for anti-Her2 antibody-drug conjugates. Zhang X; Huang AC; Chen F; Chen H; Li L; Kong N; Luo W; Fang J Antib Ther; 2022 Jan; 5(1):18-29. PubMed ID: 35146330 [TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Antibody Drug Conjugates for Lymphoma. Russler-Germain DA; Kahl BS Oncology (Williston Park); 2020 Dec; 34(12):522-534. PubMed ID: 33395492 [TBL] [Abstract][Full Text] [Related]
15. Antibody-Drug Conjugates for Breast Cancer. Marmé F Oncol Res Treat; 2022; 45(1-2):26-36. PubMed ID: 34915488 [TBL] [Abstract][Full Text] [Related]
16. Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies. He J; Zeng X; Wang C; Wang E; Li Y MedComm (2020); 2024 Aug; 5(8):e671. PubMed ID: 39070179 [TBL] [Abstract][Full Text] [Related]
17. Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. Chu Y; Zhou X; Wang X J Hematol Oncol; 2021 Jun; 14(1):88. PubMed ID: 34090506 [TBL] [Abstract][Full Text] [Related]
18. Introduction to Antibody-Drug Conjugates. Pettinato MC Antibodies (Basel); 2021 Oct; 10(4):. PubMed ID: 34842621 [TBL] [Abstract][Full Text] [Related]
19. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development. Singh D; Dheer D; Samykutty A; Shankar R J Control Release; 2021 Dec; 340():1-34. PubMed ID: 34673122 [TBL] [Abstract][Full Text] [Related]